Do you want to read an article? Please log in or register.
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Gout
Related content
RECOMMENDED
Rheumatoid Arthritis
Cervical Spine Involvement is very rare in Patients with Rheumatoid Arthritis Treated actively with Treat to Target Strategy. Ten-Year Results of the NEORACo Study
★ 1
Recommended by
Dr Heino Prillwitz, Faculty Member
J Rheumatol.
Sandström T, Rantalaiho V, Yli-Kerttula T, Kautiainen H, Malmi T, Karjalainen A, Uusitalo T, Julkunen H, Kaipiainen-Seppänen O, Paimela L, Puolakka K, Uutela T, Möttönen T, Hannonen P, Leirisalo-Repo M, Laasonen L, Kauppi M, NEO-RACo Study Group.
doi: 10.3899/jrheum.190139.
Rheumatoid Arthritis
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes
Ann Rheum Dis.
Paulshus Sundlisæter N, Aga AB, Olsen IC, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA, ARCTIC study group
doi: 10.1136/annrheumdis-
Autoimmune Disease
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
Lancet.
van Vollenhoven RF, Hahn BH, Tsokos GC, Wagner CL, Lipsky P, Touma Z, Werth VP, Gordon RM, Zhou B, Hsu B, Chevrier M, Triebel M, Jordan JL, Rose S
doi: 10.1016/S0140-
Further Publications Rheumatology
Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study
Semin Arthritis Rheum
Pascart T, Carpentier P, Choi HK, Norberciak L, Ducoulombier V, Luraschi H, Houvenagel E, Legrand J, Verclytte S, Becce F, Budzik JF
doi: 10.1016/j.semarthrit.2021.06.009
COMMENTED
Rheumatoid Arthritis
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
★ 2
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
doi: 10.1136/annrheumdis-2019-216819.
Psoriatic Arthritis
Response to Secukinumab on Synovitis using Power Doppler Ultrasound in Psoriatic Arthritis: 12-week Results from a Phase III Study, ULTIMATE
Rheumatology (Oxford)
D'Agostino MA, Schett G, López-Rdz A, Šenolt L, Fazekas K, Burgos-Vargas R, Maldonado-Cocco J, Naredo E, Carron P, Duggan AM, Goyanka P, Boers M, Gaillez C
doi: 10.1093/rheumatology/keab628
Psoriasis
Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study
J Eur Acad Dermatol Venereol.
Augustin M, Kleyn CE, Conrad C, Sator PG, Ståhle M, Eyerich K, Radtke MA, Bundy C, Mellars L, Greggio C, Cordey M, Koscielny V, Griffiths CEM
doi: 10.1111/jdv.16431.
Systemic Lupus Erythematosus
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
Swiss Med Wkly.
von Kempis J, Duetsch S, Reuschling N, Villiger R, Villiger PM, Vallelian F, Schaer DJ, Mueller RB
doi: 10.4414/smw.2019.20022.
Rheumatoid Arthritis
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study
Ann Rheum Dis.
Takeuchi T, Genovese MC, Haraoui B, Li Z, Xie L, Klar R, Pinto-Correia A, Otawa S, Lopez-Romero P, de la Torre I, Macias W, Rooney TP, Smolen JS
doi: 10.1136/annrheumdis-2018-